Nippon Chemiphar News and Activities

Nippon Chemiphar is a company listed under the stock ticker 4539 (JP).

View the org chart displaying its 10 main executives

Most searched biographies at Nippon Chemiphar

• Kazushiro Yamaguchi, President, Chief Executive Officer
• Yuji Harada, Director
• Koki Hayamizu, Director

Create your alert
to follow the executive moves at Nippon Chemiphar.

Nippon Chemiphar has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Nippon Chemiphar

Social media about Nippon Chemiphar

• Nippon Chemiphar on Wikipedia, Google News & Yahoo Finance
• Nippon Chemiphar on LinkedIn, X (Twitter) & YouTube